<?xml version="1.0" encoding="UTF-8"?>
<p id="par0010">There is no registered treatment or vaccine for this disease [
 <xref rid="bib0035" ref-type="bibr">7</xref>]. For the treatment of affected people, limited urgent use of chloroquine and hydroxychloroquine have been approved by the United States Food and Drug Administration. The use of an antiviral drug called Favilavir as a treatment for coronavirus has been approved by the National Medical Products Administration of China. The drug has shown efficacy in treating the disease, with very low side effects in a clinical trial involving 70 patients. The clinical trial has been ongoing in Shenzhen, Guangdong province [
 <xref rid="bib0040" ref-type="bibr">8</xref>]. This review article reported the recent observations regarding the development of the immunity level in the human body for resisting the coronavirus as an alternative solution before the invention of drugs and vaccinations.
</p>
